Form 4 for SBRA Sabra Health Care REIT, Inc.

Accepted 2026-02-12 00:00:00 ET · period of report 2026-02-10 · accession 0002003768-26-000007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2026-02-12	2026-02-10	SBRA	FLORES JESSICA	CAO, Executive VP	F - Tax	$19.15	-1,172	86.6K	-1%	-$22.4K
	2026-02-12	2026-02-10	SBRA	FLORES JESSICA	CAO, Executive VP	A - Grant	$0.00	+3,198	87.7K	+4%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-02-10	F	D	1,172	$19.15	86,572	D	—	—	(F2) Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of restricted stock units previously granted to the reporting person. (F3) Includes 25,159 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.
2	Common	Common Stock	2026-02-10	A	A	3,198	$0.00	87,744	D	—	—	(F1) Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a funds from operations-based stock unit ("FFO units") award granted on December 27, 2022, including 672 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on February 10, 2026 that the number of FFO units earned was 90.8% of the target. Upon this determination, the FFO units vested and were settled immediately. Each FFO unit represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of a funds from operations target for a performance period beginning January 1, 2025 and ending December 31, 2025.